Bristol Myers Squibb and AstraZeneca have quickly resolved patent infringement lawsuits around their blockbuster cancer immunotherapies. A federal judge in Delaware has approved the two companies’ ...
Patients were intravenously dosed with balstilimab 3 mg/kg once every 2 weeks and zalifrelimab 1 mg/kg once every 6 weeks, for up to 24 months. The primary end point was objective response rate (ORR, ...
The pathway consisting of the receptor programmed cell death 1 (PD-1; also called CD279) and its ligands, PD-L1 (B7-H1 or CD274) and PD-L2 (B7-DC or CD273), plays a vital role in the maintenance of ...
Lately, the big buzzword, when it comes to charging, has been “USB-C Power Delivery” or shortened to “USB-C PD“. Though it’s actually a lot more than just a buzzword. Anker is one of the companies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results